Tags: ccb internationalRemove, h shareRemove

China's second-biggest drug distributor prices its H-share offering below the mid-point, but at a modest 2.4% discount versus its A-shares.
By Anette Jönsson | 16 May 2011
Tag Filters
WEBCASTS
On Demand Webcasts
Magazine
FinanceAsia Magazine
FinanceAsia
May 2012